Resource Center

This section contains international research and may reference indications not approved in all regions. Please consult local approved indications before use.

Filter By:

Search
resources-top-bg
  • Ongoing research

Transforming obstetric care: The impact of patient-operated home ultrasound and remote diagnosis in hybrid prenatal care—clinical insights from four years of research and real-world application

The Pulsenmore platform demonstrates strong clinical evidence for safety, efficacy, and usability in home-based fetal well-being monitoring.
Read more
  • Ongoing research

Self-operated home trans-perineal ultrasound with visual biofeedback for prelabor maternal pushing training: A randomized controlled study

This randomized controlled study evaluates the efficacy of prelabor visual biofeedback using a self-operated home ultrasound device to enhance maternal pushing and improve obstetrical outcomes.
Read more
  • Ongoing research

Biophysical profile by self-operated clinician-guided ultrasound Vs. standard ultrasound: An observational study

BPP, obtained by the Pulsenmore ES ultrasound device, operated by lay users, during synchronized telehealth guidance, demonstrates high accuracy and reliability for clinical use compared to standard BPP.
Read more
  • Marketing materials

Pulsenmore clinician brochure

Pulsenmore Clinician Brochure

Request the document

Read more
  • Marketing materials

Pulsenmore ES product specifications

Pulsenmore ES Product specifications

Click On The Read More Below To Request The Document

Read more
  • Marketing materials

Pulsenmore ES patient brochure

Pulsenmore Patient brochure

Click On The Read More Below To Request The Document

Read more
resources-bottom-bg

the news pulse

We invite you to keep up to date with the latest updates by registering to our quarterly newsletter

Subscribe
news-pulse-doctor
news-pulse-lady1
news-pulse-couple
news-pulse-lady2
about-collaborations-bottom-bg

FAQ

Frequently asked question

To begin working with Pulsenmore, clinicians or healthcare organizations can submit a request through the contact form and indicate their interest in a collaboration. Our team will follow up to introduce the system, review clinical and operational needs, and confirm alignment with your care model.

Once aligned, a service agreement is established. From that point, eligible patients can obtain the device through authorized channels and receive remote monitoring services as part of the clinician’s care offering.

No. Pulsenmore does not replace diagnostic or scheduled in-clinic ultrasound examinations.

Pulsenmore supports secure access to scan data, which can be referenced or documented in the EMR in accordance with institutional policies.

Pulsenmore is used as an adjunct within physician-defined care pathways. Use is determined by patient risk profile and clinical judgment and does not replace standard prenatal imaging schedules.

Pulsenmore collects four types of data:

• Service logs: Application usage logs, such as performance logs and errors.

• Technical information about the smartphone: Smartphone capabilities, application version, language, etc.

• Clinical information: Ultrasound clips scan time (see Privacy Statement)

• Interpreter Data: The identifiers of the clinicians that interpret the scans.me, scan measurements and last menstrual period (LMP).

The Pulsenmore was designed to follow ALARA (As Low As Reasonably Achievable) principles as follows:

The system supports only low frequency (2-5MHz), the duration of the scan is limited up to 3 minutes in the App guided mode, or at the clinician’s discretion in the clinician guided mode, only clinician can modify the ultrasound parameters (i.e., depth, gain, frequency etc.), each scan is enabled only upon the approval of a medical professional. The system was authorized by FDA through the de novo classification process.

Explore More

Pulsenmore is provided through participating healthcare providers. Ask your doctor if Pulsenmore is part of their prenatal care offering. If they work with us, they can prescribe the device, allowing you to purchase it and start using the service as part of your pregnancy care.

Pulsenmore is designed for use from week 14 of pregnancy and for single-fetus pregnancies. To ensure accurate monitoring and continuous clinical feedback, each device is personal and intended to be used only by you throughout your current pregnancy, keeping you securely connected to your care team.

Because it gives you peace of mind when you need it most. Pulsenmore lets you check on your baby from the comfort of your home, while staying connected to real medical care. It’s the only at-home ultrasound solution where every scan is reviewed by qualified medical professionals, so you get trusted clinical insight, not uncertainty.

Yes. Pulsenmore is based on the same ultrasound technology used routinely in clinics. Scans are performed within established safety guidelines and reviewed by a medical professional, so you receive reliable clinical insight while maintaining the safety of both you and your baby.

Every scan requires medical interpretation, and its important to wait until the files are fully uploaded. You are not expected to understand or interpret the ultrasound scans; follow the app’s instructions to scan, and receive a response from skilled ultrasound professionals .

Yes, the device is reliable and was tested, validated and approved for use in the US, Europe, Australia, Brazil, Switzerland, the UK, Colombia and Israel. Over 200,000 successful scans have been performed since the launch of the technology. These numbers demonstrate that women can confidently scan themselves, as the diagnoisis it self is being done by a trained clinical team. The remote clinical team can accurately identify parameters related to fetal vitality, such as fetal heartbeat, fetal movements, and amniotic fluid volume, based on these scans.

Explore More